Ground Truth Labs

Ground Truth Labs

AI biomarker quantification for digital pathology

Overview

Ground Truth Labs provides AI-powered biomarker quantification from digital pathology. It analyzes routine histopathology slides to quantify spatial biomarkers, serving pharmaceutical companies, CROs, and healthcare providers. Its platform requires no special staining or obscure data, enabling seamless integration into existing workflows. The company offers its AI-driven biomarker quantification as a service through subscriptions, service contracts, and partnerships. Compared with competitors, it emphasizes deriving actionable, spatial biomarker insights from standard slides and optimizing current data workflows rather than building separate data requirements. The goal is to improve cancer patient outcomes by delivering insights that inform drug development, clinical trial decisions, and clinical diagnosis.

About Ground Truth Labs

Simplify's Rating
Why Ground Truth Labs is rated
C+
Rated B on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$4.3M

Headquarters

London, United Kingdom

Founded

2019

Get referred to Ground Truth Labs

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • EHA 2026 Incyte work linked higher baseline fibrosis to progression in lower-risk patients.
  • AI augmentation more than doubled consensus odds in 1,000 cases across 15 pathologists.
  • Oxford Science Enterprises backs GTL, strengthening credibility with biopharma and clinical partners.

What critics are saying

  • $4.3M funding on 2023 launch supports a narrow runway against capital-hungry diagnostics rivals.
  • Commercial traction is still thin; public evidence shows collaboration, not scaled revenue.
  • Single-disease focus on bone marrow exposes existential risk if MPN programs stall or fail regulatory adoption.

What makes Ground Truth Labs unique

  • Oxford-built bone marrow AI measures fibrosis, megakaryocytes, blasts, and plasma cells objectively.
  • CIF and MC quantify standard slides, avoiding special stains or obscure data requirements.
  • Phase II trial and EHA 2026 results show multicenter, clinically validated pathology algorithms.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$4.3M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$4.3M
Ground Truth Labs

Benefits

Remote Work Options

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

-7%

1 year growth

0%

2 year growth

9%
PR Newswire
Jan 28th, 2026
Tauth Labs certified to issue C2PA content authentication credentials backed by Adobe, Google and OpenAI

Tauth Labs has been certified by the Coalition for Content Provenance and Authenticity (C2PA) as a Certificate Authority for issuing content authentication credentials. The certification allows the company to provide credentials recognised by major platforms including Adobe, Google, OpenAI and LinkedIn. The New York-based company's TauthID solution uses user verification, watermarks and content credentials to authenticate digital content, with optional blockchain logging. Tauth Labs focuses on serving clients in communications, financial services and local government sectors. The company's tools integrate into content management systems and offer features including branded authentication credentials, browser plugins and fake detection capabilities. C2PA's technical standards help verify digital content authenticity and track changes made to it, addressing concerns about AI-generated misinformation.

Ground Truth Labs
Jun 29th, 2023
GTL | Blog - GTL raises $4.3M to launch commercially with AI biomarkers

Quantitative, fast, and novel AI biomarkers for tissue analysis - with results in the context of validated clinical data.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Ground Truth Labs right now.

Find jobs on Simplify and start your career today

We update Ground Truth Labs's jobs every few hours, so check again soon! Browse all jobs →